Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...
North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over ... relating to their glucose monitoring products, which estimate blood sugar levels.
Adults in the US who want to measure their blood glucose levels using ... The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a ...
Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead the U.S. market for CGMs, agreed on Dec. 20 to resolve all outstanding patent ...
Technology has come a long way since the first blood glucose meter was developed by Anton ... with 2.5 million rings sold globally. Dexcom meanwhile currently occupies around 74% of the CGM ...